Hydroxychloroquine-induced hyperpigmentation in a patient with anti-synthetase syndrome
Hydroxychloroquine is a widely prescribed antimalarial drug to treat immune-mediated diseases, with a good safety profile. We present the case of a 37-year-old woman, Fitzpatrick’s phototype IV, who presented to our outpatient Dermatology Department with a 1-year history of symmetrical blue-gray dis...
Saved in:
| Main Authors: | Claúdia Brazão, Raquel Campanilho-Marques, Pedro de Vasconcelos, Luís Soares-de-Almeida, Paulo Filipe |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sociedade Portuguesa de Dermatologia e Venereologia
2024-10-01
|
| Series: | Revista da Sociedade Portuguesa de Dermatologia e Venereologia |
| Subjects: | |
| Online Access: | https://www.portuguesejournalofdermatology.com/frame_eng.php?id=181 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hydroxychloroquine-induced Sweet’s Syndrome: A Case Report and Literature Review
by: Gustavo Almeida-Silva, et al.
Published: (2025-01-01) -
Coexistence of anti-synthetase syndrome, myasthenia and scleroderma: A scarce case report
by: Sameh Sayhi, et al.
Published: (2024-09-01) -
Sporadic inclusion body myositis in the rheumatology clinic
by: Fernando Henrique Carlos de Souza, et al.
Published: (2020-01-01) -
Idiopathic inflammatory myopathies: Contributions from India
by: Anand Narayan Malaviya
Published: (2020-01-01) -
Hydroxychloroquine-induced auditory toxicity
by: Abhishek Patil, et al.
Published: (2020-01-01)